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OBJECTIVES: To evaluate the feasibility of CT pulmonary angiography for identification of naturally occur-
ring pulmonary thromboembolism in dogs using predefined diagnostic criteria and to assess the ability 
of echocardiography, cardiac troponins, D-dimers and kaolin-activated thromboelastography to predict 
the presence of pulmonary thromboembolism in dogs.
METHODS: Twelve dogs with immune-mediated haemolytic anaemia and evidence of respiratory distress 
were prospectively evaluated. Dogs were sedated immediately before CT pulmonary angiography using 
intravenous butorphanol. Spiral CT pulmonary angiography was performed with a 16 detector-row 
CT scanner using a pressure injector to infuse contrast media through peripheral intravenous cath-
eters. Pulmonary thromboembolism was diagnosed using predefined criteria. Contemporaneous tests 
included echocardiography, arterial blood gas analysis, kaolin-activated thromboelastography, D-dimers 
and cardiac troponins.
RESULTS: Based on predefined criteria, four dogs were classified as pulmonary thromboembolism posi-
tive, three dogs were suspected to have pulmonary thromboembolism and the remaining five dogs 
had negative scans. The four dogs identified with pulmonary thromboembolism all had discrete filling 
defects in main or lobar pulmonary arteries. None of the contemporaneous tests was discriminant for 
pulmonary thromboembolism diagnosis, although the small sample size was limiting.
CLINICAL SIGNIFICANCE: CT pulmonary angiography can be successfully performed in dogs under seda-
tion, even in at-risk patients with respiratory distress and can both confirm and rule out pulmonary 
 thromboembolism in dogs.
INTRODUCTION
Pulmonary thromboembolism (PTE) is the obstruction of the 
pulmonary artery or its branches by thrombi and is a major cause 
of morbidity and mortality in dogs with immune- mediated 
 haemolytic anaemia (IMHA) (Reimer et al. 1999,  Scott-Moncrieff 
et al. 2001). Dogs with IMHA are predisposed to PTE potentially 
because of an associated hypercoagulable state (Fenty et al. 2011, 
Goggs et al. 2012) that may result from increased intravascular 
tissue factor expression secondary to the marked inflammatory 
response that accompanies the disease (Piek et al. 2011, Kidd & 
Mackman 2013). There is also evidence of platelet activation in 
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The aims of this pilot study were therefore to evaluate the fea-
sibility of CTPA for identification of naturally occurring PTE in 
dogs using predefined diagnostic criteria, and to evaluate the pre-
dictive ability of echocardiography, cardiac troponins, D-dimers 
and kaolin-activated thromboelastography (TEG) for canine 
PTE diagnosis.
MATERIALS AND METHODS
Sample size
A cohort of 12 dogs with IMHA was predetermined for this 
pilot study. Previous studies suggest 32 to 80% dogs with IMHA 
have postmortem evidence of PTE (Klein et al. 1989, Carr et al. 
2002). It was therefore estimated that 4 to 10 dogs with IMHA 
and evidence of respiratory distress would have PTE detectable 
by CTPA and that this would provide sufficient positive and 
negative cases to evaluate the feasibility of CTPA for diagnosis 
of canine PTE.
Animals
Twelve client-owned dogs diagnosed with IMHA admitted to 
the Queen Mother Hospital for Animals, The Royal Veterinary 
College between November 2009 and January 2013 were prospec-
tively evaluated. Written, informed owner consent was obtained 
at hospital admission. The diagnosis of IMHA was based on the 
presence of regenerative anaemia and at least one of the follow-
ing: positive in-saline agglutination test, positive direct antibody 
(Coombs’) test or moderate-marked spherocytosis identified on 
peripheral blood smear examination by a board-certified clinical 
pathologist. Additional inclusion criteria were the combination 
of either tachypnoea (respiratory rate >20/min) or PaCO
2
<32 
mmHg, plus either increased respiratory effort or hypoxaemia 
(SaO
2
<95% or PaO
2
<85 mmHg on room air or a PaO
2
:FiO
2
 
ratio of <400 mmHg on supplemental oxygen). Cases were ineli-
gible if there was concurrent thrombocytopenia (<100×103/µL) 
or bodyweight <7·5 kg. Signalment, previous medical history 
and physical examination findings at admission were recorded.
Ethics statement
This study was approved by the institutional ethics and welfare 
committee (Ref: 20111133R). Case management was deter-
mined by the primary attending clinicians. To minimise risks 
associated with sedation, all cases were stabilised as appropri-
ate prior to CTPA and flow-by oxygen provided during the 
procedure. To minimise risks associated with contrast material 
administration, dogs with known hypersensitivity to iodinated 
contrast agents were excluded. Fluid or electrolyte disorders were 
corrected prior to CTPA. In cases with renal insufficiency, fluid 
diuresis with physiologic saline following CTPA was at the pri-
mary clinician’s discretion.
CTPA
Dogs were sedated immediately before CTPA using a dose of 
0·3 mg/kg butorphanol (Torbugesic 1%; Zoetis) intravenously 
and positioned in sternal recumbency. Spiral CT pulmonary 
dogs with IMHA (Weiss & Brazzell 2006). As such, both anti-
coagulants and antiplatelet agents are used to reduce PTE risk 
and manage thrombotic complications, but are often empirically 
prescribed due to difficulties with definitively identifying PTE 
antemortem (Goggs et al. 2009).
In humans, rapid, multi-slice spiral computed tomography 
pulmonary angiography (CTPA) is central to PTE diagnosis 
(Fesmire et al. 2011). CTPA studies are obtained by simultane-
ous thoracic CT scanning and bolus injection of contrast media. 
Iodinated contrast agents are rapidly infused through peripheral 
catheters using a pressure injector, linked electronically to the 
scanner to maximally enhance the pulmonary arteries (Habing 
et al. 2011). Occlusive or partial filling defects in pulmonary 
arteries are diagnostic for PTE (Wittram et al. 2004), while a 
normal CTPA study helps to rule out PTE as the cause of respira-
tory distress, unless the index of suspicion is very high (Torbicki 
et al. 2008). Multi-detector-row or multi-slice CT scanners are 
increasingly available in veterinary medicine and permit imaging 
of the whole thorax without the need for general anaesthesia. In 
dogs, multi-slice CT angiography has been used for experimental 
PTE studies (Takahashi et al. 2008), and to identify a descending 
aortic thrombus in a dog with spirocercosis (Kirberger & Zam-
belli 2007). CTPA has been used to investigate the incidence 
of PTE following non-cemented total hip arthroplasty in dogs, 
although no evidence of PTE was identified (Tidwell et al. 2007). 
CTPA has been successfully used to diagnose pulmonary embo-
lism in dogs with naturally occurring heartworm disease (Jung 
et al. 2010).
Although in humans CTPA is the definitive test for PTE, 
other diagnostics are used to determine which patients require 
advanced imaging and for severity scoring to guide management. 
In humans presenting with compatible clinical signs but no prior 
thrombotic history, rapid quantitative D-dimer assays are per-
formed prior to imaging (Wells et al. 2000, Huisman & Klok 
2013). Where PTE is present, echocardiography and cardiac 
biomarkers including cardiac troponins can quantify the haemo-
dynamic consequences of PTE and provide prognostic informa-
tion. In humans with PTE, serum cardiac troponin values are 
highly correlated with cardiac myocyte injury, degree of cardiac 
dysfunction and with prognosis (Janata et al. 2003, Becattini 
et al. 2007). Typical echocardiographic findings in dogs with 
PTE include right ventricular (RV) dilatation, pulmonary arterial 
hypertension and paradoxical septal motion (Venco et al. 1998, 
Johnson et al. 1999). In humans with severe PTE, the RV apex is 
spared the hypokinesis that affects the remainder of the free wall. 
This apical sparing (the McConnell sign) is highly specific for 
PTE in humans, but has not been reported in dogs (McConnell 
et al. 1996). More recently, echocardiographic measurement of 
the tricuspid annular plane systolic excursion (TAPSE) and right 
ventricular myocardial performance index (TEI index) have been 
reported to be of value in humans with acute PTE (Park et al. 
2008, Rydman et al. 2010, Park et al. 2012). To date, studies 
of D-dimers, cardiac troponins and echocardiography have not 
been carried out in dogs with PTE but might improve the initial 
assessment of PTE risk and provide prognostic information in 
known PTE cases.
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complete blood counts (CBC) were collected into potassium 
EDTA tubes. Samples for serum biochemistry were collected 
into gel separator tubes. For TEG and D-dimer determina-
tions blood was collected into 3·2% liquid sodium citrate tubes. 
CBCs and serum biochemistry were performed using automated 
analysers (Cell-Dyn 2500; Abbott Laboratories and ILAB 600; 
Instrumentation Laboratory) and the values were cross-checked 
by board-certified clinical pathologists. Samples for arterial 
blood gas analysis were collected by direct arterial puncture into 
non-vacuum heparinised syringes (Preset syringe; BD) and mea-
sured immediately with a point-of-care analyser (Stat-Profile 
9; Nova Biomedical). During normal working hours, plasma 
D-dimers were analysed using a latex agglutination method 
(Helena Biosciences). Outside normal hours, plasma D-dimers 
were assayed using a quantitative point-of-care assay (Nycocard 
D-dimer; Axis-Shield POC) validated for use in dogs (Dewhurst 
et al. 2008). Cardiac troponin I (cTnI) concentrations were mea-
sured in serum using an automated immunoassay method previ-
ously validated in dogs (Spratt et al. 2005).
Thromboelastography
To avoid time-dependent alterations in TEG parameters, samples 
were held at room temperature (~20°C) for 30 minutes before 
analysis (Wiinberg et al. 2005). Kaolin-activated TEG assays 
were run according to the manufacturer’s instructions (TEG 
5000; Haemoscope Corporation). Briefly, 1000 µL of citrated 
whole blood was added to proprietary kaolin vials prewarmed 
to room temperature and gently mixed by inversion. From this 
blood:kaolin mix, 340 µL were pipetted into a reaction cup con-
taining 20 µL of 0·2M CaCl
2
 prewarmed to 37°C. The reaction 
cup was raised to the pin and the tracing started. Assays were run 
for 90 minutes. Heparinase-treated reaction cups were used for 
dogs with indwelling IV catheters and for those receiving thera-
peutic heparin, otherwise plain reaction cups were used. Four 
variables were recorded from TEG tracings: R, K, alpha and MA 
and compared against method-specific reference intervals gener-
ated from residual blood collected for annual health screening of 
dogs from the hospital blood donation programme.
Statistical analyses
Data were collated using Excel 2010 (Microsoft) and analysed 
using Prism 5.0 (GraphPad Software).
RESULTS
Based on the predefined CTPA diagnostic criteria, four (33%) 
dogs were classified as positive for PTE, three (24%) dogs were 
suspected to have PTE and the remaining five (42%) dogs had 
negative CTPA scans. The four dogs with PTE definitively iden-
tified by CTPA all had discrete filling defects in main or lobar 
pulmonary arteries (Fig 1). Abnormalities present in the three 
dogs with scans classified as suspect included possible filling 
defects in smaller caudal lobe arteries (n=2), arterial size irregu-
larities (n=1) and multi-focal alveolar infiltrates consistent with 
thromboembolic disease (n=2). Of the five dogs with negative 
 angiography was performed using a 16-slice CT scanner (Mx8000 
IDT; Philips Healthcare). Initial precontrast survey CT scans of 
the thorax were performed with scan time <30 seconds. Boluses 
of 2 mL/kg (600 mg/kg) of 300 mg I/mL iohexol (Omnipaque 
300; GE Healthcare) were then administered via peripheral intra-
venous catheters at 2 to 3 mL/s dependent on bodyweight using 
a pressure injector (Stellant; Medrad) with a maximum injection 
pressure of 150 psi. CT images were acquired immediately after 
the beginning of the contrast injection in order to capture the 
pulmonary artery phase. CT scan parameters were 120 kV, 150 
to 250 mAs (dependent on patient size), 3 mm slice thickness, 
1·5 mm increment, 0·688 pitch and sharp filter applied. 
Criteria for PTE diagnosis
The CTPA studies were reported by board-certified radiolo-
gists at the time of the scans. Images were subsequently blindly 
reviewed by two observers (LB, VLF) and predefined criteria 
applied for PTE diagnosis (Table 1). Initial imaging reports were 
then reviewed, any discrepancies evaluated and consensus on 
diagnoses reached. 
Echocardiography
Echocardiographic examinations were performed by board-
certified cardiologists or cardiology residents directly supervised 
by board-certified cardiologists, using a dedicated cardiac ultra-
sound machine (Vivid 7; GE Healthcare). All scans were subse-
quently reviewed (VLF) and a judgement was made regarding 
the presence or absence of the McConnell sign (apical sparing of 
right ventricular hypokinesis). Pulmonary artery (PA) pressures 
were estimated using spectral Doppler echocardiographic blood 
flow velocities of tricuspid and pulmonic insufficiency. The right 
ventricular Tei index and the tricuspid annular plane systolic 
excursion (TAPSE) normalised to aortic diameter were calculated 
as previously reported (Teshima et al. 2006, Pariaut et al. 2012).
Blood sampling and clinical pathology
Blood samples were collected by jugular venepuncture using 21 
G needles and appropriately sized syringes and immediately ali-
quoted into 1·1 or 1·3 mL non-vacuum, polypropylene tubes 
(Paediatric tube; International Scientific Supplies). Samples for 
Table 1. A summary of the criteria used for diagnosis 
of pulmonary thromboembolism (PTE) by computed tomog-
raphy pulmonary angiogr aphy (CTPA) in this study
PTE diagnosis Criteria (only one required per category)
Positive Complete pulmonary arterial occlusion.
Central intraluminal arterial filling defect(s) present.
Peripheral intraluminal arterial filling defect(s) present.
Suspicious Luminal irregularities in central or peripheral pulmonary 
arteries.
Differences in contralateral arterial luminal density.
Multi-focal alveolar pattern with no probable alternative 
diagnosis.
Negative None of the above.
Only one criterion in the positive category was necessary for that classification to be 
assigned. If none of these criteria were satisfied, then any one of the criteria in the 
suspicious category led to classification of the patient as suspicious for PTE. A negative 
diagnosis was only made when none of the criteria listed were satisfied
R. Goggs et al.
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confirmed or suspected in 58% of dogs with IMHA and respira-
tory distress, values consistent with previous postmortem reports 
of similar populations (Klein et al. 1989, Carr et al. 2002). These 
findings support the assertion that PTE is common in these dogs, 
and that CTPA is useful for confirming the diagnosis.
The present study is based on the premise that CTPA repre-
sents the best available technique for the identification of PTE 
in dogs. CTPA is recommended for diagnosis of massive PTE 
in humans (Torbicki et al. 2008) and for investigation of those 
with appropriate clinical probability scores. No studies in dogs 
have yet compared CTPA with more established techniques 
such as ventilation/perfusion (V/Q) scanning or selective angi-
ography, or sought to incorporate probability assessments into 
clinical decision making. There are several potential advantages 
of CTPA over these tests which are less widely available, require 
more involved radiation management protocols or necessitate 
invasive pulmonary artery catheter placement. It is not yet clear 
that the benefits and diagnostic capabilities of CTPA in humans 
will directly translate to dogs, particularly given the inherently 
different anatomy and patient size. Work establishing multi-slice 
CTPA protocols including those for bolus-tracking studies has 
recently been published, paving the way for greater use of CTPA 
in dogs (Drees et al. 2011, Cassel et al. 2013).
Where PTE was suspected rather than confirmed, multiple 
small emboli may have been present in mainstem vessels or 
emboli present only in subsegmental vessels impairing diagnos-
tic ability. In humans, the two major causes of indeterminate 
CTPA scans are motion artefacts and poor contrast enhance-
ment (Jones & Wittram 2005). Both are possible using a 
sedated CTPA protocol in dogs given that breath holding to 
minimise motion artefact and to improve lung aeration can-
not be achieved. These potential issues must be considered 
when undertaking and interpreting CTPA scans. Repeat scans 
or reconstructions with narrower slices might enable definitive 
identification or exclusion.
scans, one dog had evidence of cardiac enlargement and another 
dog had evidence of atelectasis. In the three other dogs with neg-
ative CTPA scans an alternative diagnosis to explain the dog’s 
respiratory distress was not identified.
Ten dogs underwent echocardiography; nine had evidence 
of pulmonic regurgitation and six had tricuspid regurgitation. 
TAPSE values and Tei indices were calculable in most patients 
that underwent echocardiography. A subjective assessment 
of right ventricular wall motion was made in all patients that 
underwent echocardiography. Apical sparing of right ventricular 
hypokinesis was subjectively identified in three patients, but this 
finding did not correlate with CTPA diagnosis.
Additional clinicopathologic data collected from the 12 dogs is 
summarised in Table 2. All blood samples were collected within 4 
hours of the CTPA scan being performed. Correlations between 
clinicopathologic variables and CTPA diagnosis were assessed 
by visual inspection of scatterplots (Fig 2), but no variable was 
clearly discriminant for CTPA diagnosis. In terms of outcome, 
seven dogs survived to discharge, three dogs were euthanised and 
two dogs died. The non-survivors were evenly distributed across 
the three CTPA diagnosis groups. None of the cardiopulmonary 
variables (arterial blood-gases, echocardiographic indices, car-
diac troponins) assessed were significantly different between the 
survivors and the non-survivors. Of the coagulation parameters 
measured, the kaolin-TEG variables were most associated with 
outcome, although only the R time of non-survivors was signifi-
cantly longer than in survivors (P=0·0235, unpaired Student’s t 
test; Fig 3).
DISCUSSION
This study describes the use of CTPA to establish definitive 
antemortem diagnoses of naturally occurring PTE in dogs with 
IMHA. Using CTPA, PTE was confirmed in 33% dogs and either 
A B
FIG 1. CT pulmonary angiography (CTPA) from two dogs with immune-mediated haemolytic anaemia. (A) Positive CTPA study diagnostic for PTE. 
Intraluminal filling defects can be clearly seen in both the right (arrow) and left (arrowhead) main pulmonary arteries. The filling defect in the left 
pulmonary artery is only partial at this level. (B) Negative CTPA study which rules out PTE in this patient. There is normal opacification of both left at 
right pulmonary arteries by contrast at this level. No aortic filling defects were noted in this study
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FIG 2. Scatterplots of clinicopathologic and cardiopulmonary parameters stratified by CT pulmonary angiography (CTPA) diagnosis including 
(A) Kaolin-activation thromboelastography maximum amplitude; (B) PaO2:FiO2 ratio from arterial blood gas analyses; (C) cardiac troponin I values 
and (D) pre-ejection period/right ventricular ejection time (PEP/RVET) values. Solid horizontal lines represent the median value. Grey shaded areas 
between dotted lines represent normal reference intervals
FIG 3. Scatterplots of the four principle thromboelastography variables, reaction time (R), clot formation time (K), clot formation angle (alpha) and 
maximum amplitude (MA) stratified by outcome. Solid horizontal lines represent the median value. Grey shaded areas between dotted lines represent 
normal reference intervals
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The cause of respiratory distress in the dogs with negative 
CTPA scans is unclear. In humans, multi-slice CTPA has a low 
false-negative rate (sensitivity 83 to 100%) (Cronin et al. 2008). 
Sensitivity is lower when emboli are confined to subsegmental 
vessels (Goodman et al. 1995), although multi-slice scans have 
improved detection rates in humans (Ghaye 2007), particularly 
as slice thickness is reduced (Jung et al. 2011). If these three dogs 
were truly PTE-negative, then non-respiratory causes of tachy-
pnoea including reduced blood oxygen content, metabolic acido-
sis, pain, anxiety and medications such as glucocorticoids are all 
plausible causes in dogs with IMHA (Hall & Lee 2009).
Surprisingly, no clinicopathologic variable assessed reliably 
related to the CTPA diagnosis. For instance, two dogs with defin-
itively identified PTE had a PaO
2
:FiO
2
 ratio above 400 mmHg. 
Similarly, two dogs without CTPA evidence of PTE had cTnI 
values above 5 ng/mL (reference value <0·23 ng/mL). This may 
suggest these diagnostic tests are of limited value for PTE diag-
nosis in dogs, although the small sample size limits the ability to 
draw definitive conclusions. Each parameter assessed has distinct 
sensitivity and specificity characteristics and diverse causes of 
false-positive or false-negative results. For example, oxygenation 
impairment is related to pulmonary vascular compromise, thus 
PTE might be clearly visible on CTPA but have limited impact 
on PaO
2
:FiO
2
 ratio (McIntyre & Sasahara 1971). Myocardial 
hypoxia or dysfunction can occur in IMHA and might have 
been responsible for increased cTnI values in dogs with negative 
CTPA scans (Prosek & Ettinger 2010). Timing of measurement 
in relation to the PTE event is also important for certain param-
eters. D-dimers should be measured within 1 to 2 hours of the 
suspected event because they peak rapidly after PTE and decline 
to reference values within 24 hours (Ben et al. 2007). In contrast, 
early measurement of cardiac troponins can lead to false-negative 
findings in PTE (Ferrari et al. 2012). This study was based on the 
premise that CTPA represents the optimal diagnostic method for 
PTE diagnosis in dogs and therefore compared the performance 
of other diagnostics to it. This assumption may not be true for 
all cases, however, which might explain why some dogs with 
negative CTPA scans had high cTnI values for instance. Further 
evaluation of both CTPA and the point-of-care tests for identifi-
cation of PTE in dogs is clearly necessary before firm conclusions 
about their value in PTE diagnosis can be drawn.
There were five non-survivors in this study. Three dogs were 
euthanised due to the severity of the underlying disease, failure 
to respond to therapy and the development of complications 
including PTE and anuric kidney failure. One dog with suspect-
ed PTE suffered respiratory arrest and died but necropsy was not 
performed in that case. Necropsy was performed in three cases (2 
positive for PTE and 1 negative for PTE). In both cases where 
PTE was diagnosed by CTPA antemortem, PTE was identified 
postmortem. No PTE was identified in the dog with negative 
CTPA, which was euthanised due to development of acute kid-
ney injury.
Few of the variables measured were associated with outcome, 
although this study was not designed to assess outcome in these 
dogs. None of the cardiopulmonary variables were useful for 
outcome stratification. The association between the four TEG 
variables and outcome in this study was consistent with previous 
studies of IMHA, wherein dogs with “relative hypocoagulabil-
ity” were less likely to survive than those with hypercoagulable 
tracings (Sinnott & Otto 2009, Goggs et al. 2012). The lack of 
correlation between CTPA results and outcome in these patients 
is noteworthy and is most likely explained by the low case num-
bers. The argument for definitively diagnosing PTE with CTPA 
is to enable administration of specific treatment to dogs with 
thromboembolic disease, such as antithrombotic therapies or 
supportive medications including sildenafil, which may improve 
outcome. Definitive PTE diagnosis is a requisite for interven-
tional clinical trials, which in humans have identified potentially 
beneficial interventions for PTE such as rivaroxaban and low-
dose thrombolysis (Büller et al. 2012, Sharifi et al. 2013). Such 
studies in dogs are not currently available, but might be possible 
once PTE can be routinely diagnosed.
It is recognised that this study has limitations. This investiga-
tion was designed as a pilot study, with a small planned enroll-
ment, but clearly represents a small sample of the dogs treated at 
the institution. All dogs in this study were deemed high-risk for 
PTE. Although this increased the pretest probability of PTE, it 
did enable evaluation of the feasibility of CTPA for PTE diag-
nosis in dogs. The study was also limited by the lack of a gold-
standard against which to compare CTPA. V/Q scintigraphy and 
selective pulmonary angiography have previously been used for 
PTE diagnosis in dogs (Suter 1984, Bunch et al. 1989, Johnson 
et al. 1999), but V/Q scanning was not available and selective 
pulmonary angiography is an invasive and potentially high-risk 
procedure in unstable cases.
This study was undertaken prospectively to maximise the 
completeness of data collection. Despite this precaution, some 
data are missing. In two cases the omission of data was due to 
deterioration in the dog’s condition. The missing data limit the 
ability to evaluate the predictive ability of non-imaging diagnos-
tic tests for the presence of PTE; however, this study does provide 
a clear basis for future, larger studies in this area.
In summary, the feasibility of CTPA for identification of natu-
rally occurring PTE in dogs has been established and that CTPA 
can be successfully performed under sedation, even in cases with 
respiratory distress, has been demonstrated. This study also shows 
that CTPA can both confirm and rule out PTE in major pulmo-
nary arteries in these cases. Although few of the other diagnostic 
tests for PTE correlated with CTPA in this study, larger studies 
of this and other populations can now be undertaken using the 
protocols established here to more fully assess their diagnostic 
potential.
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SUPPORTING INFORMATION
The following supporting information is available for this article: 
Table S1. Summary historical, physical examination, diagnostic, 
clinicopathologic and treatment data for the 12 dogs with IMHA 
included in this study.
